Amorepacific Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Los beneficios de Amorepacific han disminuido a una tasa media anual de -18.1%, mientras que en la industria Personal Products los beneficios crecieron en un 5% anualmente. Los ingresos han ido disminuyendo a una tasa media de 7.2% al año. La rentabilidad financiera de Amorepacific es de 3.6%, y sus márgenes netos son de 4.9%.

Información clave

-13.9%

Tasa de crecimiento de los beneficios

-14.0%

Tasa de crecimiento del BPA

Crecimiento de la industria Personal Products	3.8%
Tasa de crecimiento de los ingresos	-7.7%
Rentabilidad financiera	3.4%
Margen neto	3.9%
Última actualización de beneficios	31 Mar 2024

Actualizaciones de resultados anteriores recientes

Amorepacific's (KRX:090430) Profits May Not Reveal Underlying Issues

Mar 14

Does Amorepacific's (KRX:090430) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 14

Recent updates

Does Amorepacific's (KRX:090430) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 14

Amorepacific Corporation (KRX:090430) Shares Could Be 30% Above Their Intrinsic Value Estimate

Jan 31

The Trends At Amorepacific (KRX:090430) That You Should Know About

Jan 18

Amorepacific Corporation's (KRX:090430) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Jan 05

Is Amorepacific Corporation (KRX:090430) An Attractive Dividend Stock?

Dec 21

Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly

Dec 06

Could The Amorepacific Corporation (KRX:090430) Ownership Structure Tell Us Something Useful?

Nov 20

Desglose de ingresos y gastos

Cómo gana y gasta dinero Amorepacific. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

KOSE:A090430 Ingresos, gastos y beneficios (KRW Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Mar 24	3,671,719	143,850	2,131,903	104,306
31 Dec 23	3,673,964	152,522	2,104,083	103,214
30 Sep 23	3,835,683	140,395	2,167,096	100,857
30 Jun 23	3,883,262	136,604	2,163,102	100,266
31 Mar 23	3,883,600	104,331	2,158,162	99,937
31 Dec 22	4,134,933	134,475	2,253,685	97,025
30 Sep 22	4,371,912	68,371	2,478,364	103,819
30 Jun 22	4,544,441	84,039	2,595,984	104,129
31 Mar 22	4,775,375	175,913	2,681,973	102,724
31 Dec 21	4,863,128	193,681	2,738,317	103,878
30 Sep 21	4,695,327	178,982	2,636,942	91,184
30 Jun 21	4,675,027	148,728	2,591,444	88,424
31 Mar 21	4,554,106	98,653	2,516,929	88,708
31 Dec 20	4,432,179	35,132	2,519,453	89,073
30 Sep 20	4,608,908	42,912	2,599,223	93,462
30 Jun 20	4,922,270	137,275	2,785,584	96,112
31 Mar 20	5,259,669	186,991	2,999,147	96,251
31 Dec 19	5,580,142	238,804	3,113,289	96,391
30 Sep 19	5,470,617	289,696	3,093,168	97,473
30 Jun 19	5,347,037	234,594	3,083,796	98,223
31 Mar 19	5,297,581	282,385	3,044,533	96,746
31 Dec 18	5,277,845	332,195	3,036,399	95,559
30 Sep 18	5,193,657	347,563	2,936,289	93,295
30 Jun 18	5,125,097	377,054	2,848,197	90,641
31 Mar 18	4,986,371	347,115	2,803,264	90,547
31 Dec 17	5,123,826	394,011	2,865,274	91,848
30 Sep 17	5,299,895	450,531	2,999,070	92,226
30 Jun 17	5,490,953	488,541	3,118,276	97,383
31 Mar 17	5,729,430	600,383	3,167,522	100,149
31 Dec 16	5,645,440	639,255	3,109,611	98,792
30 Sep 16	5,555,181	636,268	3,060,173	100,768
30 Jun 16	5,295,359	658,995	2,879,031	93,393
31 Mar 16	5,047,329	628,616	2,753,692	102,223
31 Dec 15	4,766,627	577,523	2,615,762	79,951
30 Sep 15	4,519,611	550,538	2,453,608	75,901
30 Jun 15	4,375,235	515,495	2,359,069	75,138
31 Mar 15	4,146,542	466,286	2,244,067	55,803
31 Dec 14	3,874,008	379,104	2,101,132	71,097
30 Sep 14	3,600,095	373,665	1,915,459	66,882
30 Jun 14	3,396,154	335,996	1,803,517	62,501
31 Mar 14	3,228,442	298,132	1,719,575	64,328
31 Dec 13	3,100,413	267,975	1,654,456	63,572
30 Sep 13	3,043,461	257,412	1,630,536	61,312
30 Jun 13	2,983,986	261,279	1,589,586	62,256

Ingresos de calidad: A090430 tiene un gran one-off gain de ₩172.5B impacto en sus últimos 12 meses de resultados financieros a 31st December, 2023.

Margen de beneficios creciente: Los actuales márgenes de beneficio (4.9%) de A090430 son superiores a los del año pasado (3.3%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de A090430 han disminuido en un 18.1% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de A090430 en el último año (33.9%) supera su media de 5 años (-18.1% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de A090430 en el último año (37.9%) superó al de la industria Personal Products 28.9%.

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de A090430 (3.6%) se considera baja.

Amorepacific Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Amorepacific's (KRX:090430) Profits May Not Reveal Underlying Issues

Full year 2023 earnings released: EPS: ₩2,609 (vs ₩1,949 in FY 2022)

Full year 2022 earnings released: EPS: ₩1,949 (vs ₩2,820 in FY 2021)

Full year 2020 earnings released: EPS ₩512 (vs ₩3,477 in FY 2019)

Does Amorepacific's (KRX:090430) Statutory Profit Adequately Reflect Its Underlying Profit?

Amorepacific Corporation to Report Fiscal Year 2020 Results on Feb 03, 2021

Recent updates

Is Amorepacific Corporation (KRX:090430) Potentially Undervalued?

A Look At The Intrinsic Value Of Amorepacific Corporation (KRX:090430)

Consensus EPS estimates increase by 11%

Investor sentiment improves as stock rises 19%

Price target increased by 13% to ₩183,958

Be Wary Of Amorepacific (KRX:090430) And Its Returns On Capital

Amorepacific Corporation (KRX:090430) Looks Just Right With A 26% Price Jump

Now 22% overvalued after recent price rise

Amorepacific (KRX:090430) Has A Pretty Healthy Balance Sheet

Amorepacific's (KRX:090430) Profits May Not Reveal Underlying Issues

Full year 2023 earnings released: EPS: ₩2,609 (vs ₩1,949 in FY 2022)

Amorepacific Corporation, Annual General Meeting, Mar 15, 2024

Amorepacific Corporation, Annual General Meeting, Mar 15, 2024

Amorepacific Unveils Research Demonstrating the Impact of Lymphatic Activating Ingredients

Now 22% overvalued after recent price rise

Upcoming dividend of ₩680 per share at 0.5% yield

New minor risk - Earnings quality

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 10%

Price target increased by 8.0% to ₩151,000

Amorepacific Corporation (KOSE:A090430) agreed to acquire additional 54.8% stake in Cosrxinc Co., Ltd. for approximately KRW 760 billion.

New major risk - Revenue and earnings growth

Consensus EPS estimates fall by 10%

Investor sentiment deteriorates as stock falls 15%

Full year 2022 earnings released: EPS: ₩1,949 (vs ₩2,820 in FY 2021)

Price target increased to ₩145,524

Upcoming dividend of ₩980 per share

Amorepacific and BTS Collaborate to Release Limited-Edition Set Featuring NEW "Butter" Lip Sleeping Mask Flavor

No independent directors

Consensus EPS estimates fall by 11%

Now 24% undervalued after recent price drop

Price target decreased to ₩132,833

Amorepacific Corporation (KOSE:A090430) entered into an agreement to acquire Tata's Natural Alchemy, LLC from Alliance Consumer Growth, LLC and M13 Ventures Management, LLC for WON 168.1 billion.

Price target decreased to ₩171,950

Amorepacific Corporation Develops First Chip-Less Wireless Electronic Skin Enabled by Semiconductors

Price target decreased to ₩180,150

Amorepacific Corporation Ordinary Shares to Be Deleted from OTC Equity

No independent directors

Investor sentiment improved over the past week

Upcoming dividend of ₩800 per share

Amorepacific Introduces Special Collaboration with BTS

Consensus EPS estimates fall to ₩7,087

Price target increased to ₩282,793

Price target increased to ₩268,464

Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly

Full year 2020 earnings released: EPS ₩512 (vs ₩3,477 in FY 2019)

Did You Miss Amorepacific's (KRX:090430) 41% Share Price Gain?

Does Amorepacific's (KRX:090430) Statutory Profit Adequately Reflect Its Underlying Profit?

Price target raised to ₩228,500

Amorepacific Corporation (KRX:090430) Shares Could Be 30% Above Their Intrinsic Value Estimate

Amorepacific Corporation to Report Fiscal Year 2020 Results on Feb 03, 2021

Analysts update estimates

Analysts update estimates

The Trends At Amorepacific (KRX:090430) That You Should Know About

New 90-day high: ₩220,500

Analysts update estimates

Amorepacific Corporation's (KRX:090430) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Is Amorepacific Corporation (KRX:090430) An Attractive Dividend Stock?

New 90-day high: ₩217,000

Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly

Could The Amorepacific Corporation (KRX:090430) Ownership Structure Tell Us Something Useful?

New 90-day high: ₩185,000

New 90-day low: ₩158,000

Analysts lower EPS estimates to ₩2,133

New 90-day high - ₩182,000

LB Investment Inc., Amorepacific Corporation (KOSE:A090430) and Smilegate Investment, Inc. acquired 23.7% stake in Baram International Co.,Ltd.

Amorepacific Corporation to Report First Half, 2020 Results on Jul 31, 2020

Desglose de ingresos y gastos

Historial de beneficios e ingresos